[STUDY OF THE ACTION OF A NEW ANTIBIOTIC, RIFAMYCIN SV].
D000900:Anti-Bacterial Agents; D004926:Escherichia coli; D007709:Klebsiella; D010118:Oxytetracycline; D010406:Penicillins; D010600:Pharmacology; D011511:Proteus; D011549:Pseudomonas; D012106:Research; D012294:Rifamycins; D012485:Salmonella typhi; D012760:Shigella; D013210:Staphylococcus; D013291:Streptococcus; D013296:Streptococcus pneumoniae
D000900:Anti-Bacterial Agents; D010406:Penicillins; D012294:Rifamycins; C023808:rifamycin SV; D010118:Oxytetracycline
DIPLOCOCCUS PNEUMONIAE; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY; KLEBSIELLA; OXYTETRACYCLINE; PENICILLIN; PHARMACOLOGY; PROTEUS; PSEUDOMONAS; RIFOMYCIN; SALMONELLA TYPHOSA; SHIGELLA; STAPHYLOCOCCUS; STREPTOCOCCUS
ETUDE DE L'ACTIVIT'E D'UN NOUVEL ANTIBIOTIQUE, LA RIFAMYCINE SV.